Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study.
about
Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominanceImmunogenicity and safety of three 2010-2011 seasonal trivalent influenza vaccines in Chinese toddlers, children and older adults: a double-blind and randomized trialAdministration of AS03B-adjuvanted A(H1N1)pdm09 vaccine in children aged <3 years enhances antibody response to H3 and B viruses following a single dose of trivalent vaccine one year later.Safety and immunogenicity of 2010–2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine: results of a randomized trialA randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of ageInfluenza vaccines: from whole virus preparations to recombinant protein technology.Canadian vaccine research networks: Vaccine safety resources for Canada.
P2860
Q28728106-B6691131-6D64-49AE-88C5-C48FC7CAFA16Q30352464-FF966ECD-A0AF-4A74-B413-97E2B5D4F7A6Q30354814-A2C1EF8D-76CE-4E8C-8551-D142BDFD50F8Q30429170-7C4A63C2-705E-480B-82D7-90C8DFFB5267Q37530395-4C1A5F39-0D17-49B8-B3CD-FA68C24CBE5FQ38160083-7A0DF3CA-9F0D-4DCC-B44B-329377F8591EQ54208188-CE384D95-3A79-4316-8065-A779E98E93B6
P2860
Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Safety and immunogenicity of 2 ...... esearch Network (PCIRN) study.
@ast
Safety and immunogenicity of 2 ...... esearch Network (PCIRN) study.
@en
type
label
Safety and immunogenicity of 2 ...... esearch Network (PCIRN) study.
@ast
Safety and immunogenicity of 2 ...... esearch Network (PCIRN) study.
@en
prefLabel
Safety and immunogenicity of 2 ...... esearch Network (PCIRN) study.
@ast
Safety and immunogenicity of 2 ...... esearch Network (PCIRN) study.
@en
P2093
P50
P1433
P1476
Safety and immunogenicity of 2 ...... esearch Network (PCIRN) study.
@en
P2093
Brian Ward
Bruce Smith
Otto G Vanderkooi
Simon Dobson
Susan Kuhn
Tobias Kollman
P304
P356
10.1016/J.VACCINE.2012.03.046
P407
P50
P577
2012-03-30T00:00:00Z